Lorus Therapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lorus Therapeutics Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trustmanic who wrote (20)	3/12/1997 8:31:00 PM
From: Teresa Howie	of 279

TO ALL: I have been followed many cheap and undervalued biotech stocks for many years. After doing an intense homework, I virtually find that Imutec Pharma Inc. seems to have the highest potential to grow on the market in the near future. IMT is curently working on a very exciting skin cancer drug (Virulizin) which has already proven to be very effective in the final clinical labs. (hint:I got a tip from people work there). I have spoken with few brokers from Toronto whom also consider IMT as their top candidate and they are closely watched for the final clinical results. After reading all the comments on this thread and it seems to me that very few investors follow this stock. I truly believe that IMT story will one day reach the investment community. For those who already get on board and patiently hold on their papers will be greatly rewarded in the near future. In fact I did make a 488% return from Biovail Corp., 84% from Allelix Biopharmaceuticals, 290% from Synsorb, 177% from Inflazyme and 140% from Biochem Pharma Inc. Don't miss this stock! Bye for now and good luck to all.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next